Alex B. Chebl

[Alex B. Chebl @AlexChebl]

@almuftifawaz @JustinSingerMD @CerebrovascLab @AmeerEHassan @NguyenThanhMD @STateshimaMD @_AdnanSiddiqui @EladLevyMD @elghanemmoh @PascalJabbourMD @AshuPJadhav @JPTsaiMD I am very saddened to hear this news. Although I did not work with him clinically we served on some committees together and met up at dinners in Michigan and I was struck by his kindness and professionalism. My most sincere condolences to his family and friends, may he RIP.

[Mohammad El-Ghanem @elghanemmoh]

@almuftifawaz @JustinSingerMD @CerebrovascLab @AmeerEHassan @NguyenThanhMD @STateshimaMD @_AdnanSiddiqui @EladLevyMD @PascalJabbourMD @AshuPJadhav @JPTsaiMD 😢

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE Diagnostic Imaging: The CAROTID RING SIGN on single-phased #CTA is a potent imaging marker to differentiate true occlusion from pseudo-occlusion with sensitivity and specificity of 0.70 and 0.94, respectively. #AHAJournals https://t.co/WUd1w8XOvs @jake_sui

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE Topical Review by @a_charidimou & @VCI_EricSmith: Cerebral microbleeds #CMBs in the setting of cerebral amyloid angiopathy #CAA: bleeding risk and safety of antithrombotic management. #AHAJournals https://t.co/PYlJRYWAZu

[Henry Ford Neuroscience @HenryFordNeuro]

Second Q&A with Drs. Entazami and Dr. Ramadan, again moderated by Dr. @AlexChebl. Thank you for your incredible insights on the limits of acute stroke care and the medical vs. surgical vs. endovascular management of the carotid web.

[Alex B. Chebl @AlexChebl]

⁦@AmyLynnAho⁩ talking at 6th Detroit Stroke Conference about Navigating the Post-Stroke Journey, highlighting the Herculean effort and costs required by patients and their care givers in their recovery post stroke. A real hero! ⁦@HenryFordNeuro⁩ ⁦@RiadRmdn⁩

[Alex B. Chebl @AlexChebl]

Honored to welcome Dr Andrew Asimos as the Keynote Speaker at @HenryFordNeuro 6th Annual Detroit Stroke Conference, On his Birthday! @OwaisAlsrouji @aboulnourh @GhadaMohamedMD @RiadRmdn

[Tudor G. Jovin, MD @TudorGJovin]

Fantastic news for carotid stenosis patients who now have more treatment options based on their specific circumstances and personal preferences as CMS decided to cover CAS in non-high risk patients.
However, CREST-2 enrollment remains as important as ever
https://t.co/eBtrhCPpDG

[AshuJadhav @AshuPJadhav]

Early Intubation in Endovascular Therapy for Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial | Stroke https://t.co/WrWCEH7UiY

[AshuJadhav @AshuPJadhav]

Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials - The Lancet https://t.co/9TIeEEnJj0

[Shadi Yaghi @ShadiYaghi2]

Our latest in collaboration with @JimSiegler @NguyenThanhMD and co-authors.
Acute basilar occlusions presenting with mild deficits based on NIHSS seem to do better with thrombectomy vs. medical treatment alone. https://t.co/gDETE5iVaQ @StrokeAHA_ASA

[Thanh Nguyen 🇺🇦 @NguyenThanhMD]

🗞️Safety & Outcome of Revascularization Treatment in Patients With Acute Stroke & COVID-19: The 🌎Global COVID-19 Stroke Registry 🧠https://t.co/AtWsVXCzhv

Outstanding work led by João Pedro Marto, @DStrambo @GeorgeNtaios Patrik Michel @CHUVLausanne with our 🌎 colleagues⬇️

[Alex B. Chebl @AlexChebl]

@StrokeAHA_ASA How can pts without TEE, imaging of entire vasculature (i.e. no duplex or TOF MRA neck allowed), prolonged EKG tele 28days or longer, or who have plaque 0-50% be called ESUS? Heterogenous pts=negative trial, remember WARSS? #ESOC23 @GhadaMohamedMD @OwaisAlsrouji @NguyenThanhMD

[Alex B. Chebl @AlexChebl]

@StrokeAHA_ASA This is unfortunate but will need to wait for subgroup analyses. It would be nice to offer distal and small vessel occlusions therapy because MT is not always feasible and pending EndoLow, may not be safe enough.

[Stroke AHA/ASA @StrokeAHA_ASA]

TIMELESS trial shows no benefit of TNK in the extended time window of 4.5-24 hours of LKW among patients with ICA/M1/M2 occlusion did not show benefit on the 90-day mRS without any signal of safety concerns. #ESOC2023

[Thanh Nguyen 🇺🇦 @NguyenThanhMD]

A phase II randomized trial of Trendelenburg position for acute moderate ischemic stroke.

https://t.co/STLp8AQDAO led by Hui-Sheng Chen et al.

[Henry Ford Neuroscience @HenryFordNeuro]

We are thrilled to welcome our new Chairman of Neurology, Dr. Brien J. Smith (Pictured here with Dr. Steven N. Kalkanis, Chairman, Henry Ford Medical Group). Read more about Dr. Smith here: https://t.co/20aHGUGAIQ @SteveKalkanisMD @HenryFordHealth

[Alex B. Chebl @AlexChebl]

ARAMIS Open label RCT DAPT vs tPA in Chinese minor stroke (NIHSS<6): median NIHSS 2. DAPT non-inferior with lower risk of deterioration and lower bleeding events. Higher NIHSS may be better w tPA. This is big deal #ISC23 @HenryFordNeuro @OwaisAlsrouji @GhadaMohamedMD @aboulnourh

[Henry Ford Health @HenryFordHealth]

"This is about giving #Detroit what every major U.S. city has and deserves: a world-class academic medical center and campus that will change the face - and the delivery - of care as this community knows it."
- @SteveKalkanisMD. Details: https://t.co/sPQS2mhyVG

[AshuJadhav @AshuPJadhav]

Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct | NEJM https://t.co/zFAV2hFMa5